Download Caring for the Child with Chronic Hepatitis B Infection

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Sexually transmitted infection wikipedia , lookup

Marburg virus disease wikipedia , lookup

Schistosomiasis wikipedia , lookup

Chickenpox wikipedia , lookup

Leptospirosis wikipedia , lookup

Herpes simplex virus wikipedia , lookup

Oesophagostomum wikipedia , lookup

Neisseria meningitidis wikipedia , lookup

Neonatal infection wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

Antiviral drug wikipedia , lookup

Human cytomegalovirus wikipedia , lookup

Hepatitis wikipedia , lookup

Hepatitis C wikipedia , lookup

Hepatitis B wikipedia , lookup

Transcript
Natural History of Hepatitis B Infection
HBeAg+/Anti-HBe–
Interpreting Hepatitis B Serology
in Patients Older than 1 year**
Caring for the
Child with Chronic
Hepatitis B Infection
HBeAg–/Anti-HBe+
HBV DNA
ALT
Normal ALT
Immune
Tolerant Phase
Immune Activation/
HBeAg Seroconversion
HBV Carrier
Reactivation
ALT ≤2x upper limit
of normal
ALT >2x upper limit of normal
ALT normal
Rising ALT
Development of Anti-HBe,
loss of HBeAg
HBsAg+/Anti-HBs–
HBsAg+/Anti-HBs–
HBsAg+/Anti-HBs–
HBeAg–/Anti-HBe+
HBeAg–/Anti-HBe+
HBeAg+/Anti-HBe–
Decreasing HBV DNA
Low HBV DNA
Rising DNA
High HBV DNA
Possible need for treatment
HBsAg
Negative
Not infected
Anti-HBs
Positive
Immune to hepatitis B
HBsAg
Negative
Not infected
Anti-HBs
Negative
Not immune to hepatitis B
HBsAg
Positive
Active infection with hepatitis B
Anti-HBs
Negative
HBeAg
Positive
With normal ALT = immune tolerant
phase of infection
Anti-HBe
Negative
With increased ALT = possible
seroconversion or consider treatment
HBsAg
Positive
Anti-HBs
Negative
With normal ALT = Hepatitis B “carrier”
HBeAg
Negative
Anti-HBe
Positive
HBV DNA
≥105 iu/mL
HBV DNA
≤104 iu/mL
Partial immune response
to hepatitis B infection with
HBeAg seroconversion
High viral load
Active replication of virus,
expected in HBeAg + patients
Low viral load
• Immune tolerant phase may last for less
than 10 years or for more than 20 years
Decreased viral replication,
expected in HBeAg – patients
**In patients under 1 year of age, antibodies may be maternal.
To verify infectious status, repeat full serology with HBV DNA
between 12 and 18 months of age.
• 0.5% of “HBV carriers” annually will clear HBsAg,
most of these will develop anti-HBs
• Up to 10% of inactive carriers may have
reactivation of viral replication and hepatitis.
These patients should be referred to Liver Clinic
For more information please contact: 416-813-7270
Constance O’Connor, MN, Nurse Practitioner
Simon Ling, MBChB, Staff Gastroenterologist
Liver Clinic, Division of Gastroenterology,
Hepatology & Nutrition,
The Hospital for Sick Children,
Toronto, Ontario, Canada
CSS 49506
A Guide for Community Healthcare Providers
Children 0-5 years of age
School-age Children
Adolescents and Young Adults
Confirm chronic infection at 12-18 months of age
Action plan:
Action plan:
with hepatitis B serology:
• All household members should be
• All household members should be
• HBsAg, Anti-HBs, HBeAg, Anti-HBe, HBV DNA
immunized against hepatitis B
• Patient should receive immunization against
Action plan:
hepatitis A and all other recommended immunizations
immunized against hepatitis B
• Patient should receive immunization against
hepatitis A and all other recommended immunizations
•All household members should be immunized
against hepatitis B
•Patient should receive immunization against
hepatitis A and all other recommended immunizations
Teaching for the child:
Teaching for the adolescent:
• General health: healthy diet, exercise
• Natural history of hepatitis B infection
• Blood and body fluid precautions
• General health: healthy diet, exercise
• Blood and body fluid precautions
Teaching for parents:
Teaching for parents:
• Disclosure of hepatitis B status
• Natural history of hepatitis B infection in childhood
• Natural history of hepatitis B infection in childhood
• Sexual transmission
• Blood and body fluid precautions
• Blood and body fluid precautions
• Alcohol
• Disclosure of hepatitis B status
• Disclosure of hepatitis B status
• OTC and prescription medication
• OTC and prescription medication
• OTC and prescription medication
• Illicit drugs
• Child-bearing
Monitoring:
Monitoring:
• Blood work every 6 months:
• Blood work every 6 months:
conjugated bilirubin, unconjugated bilirubin,
ALT, AST, GGT, albumin, creatinine, CBC, differential
• Annual hepatitis B serology:
HBsAg, HBeAg, anti-HBe, HBV DNA
• Liver ultrasound every 2 years
• Cancer risk and screening
conjugated bilirubin, unconjugated bilirubin, ALT,
Monitoring:
AST, GGT, albumin, creatinine, CBC, differential
• Blood work every 6 months:
• Annual hepatitis B serology:
HBsAg, HBeAg, anti-HBe, HBV DNA
• Liver ultrasound every 2 years
conjugated bilirubin, unconjugated bilirubin,
ALT, AST, GGT, albumin, creatinine, CBC, differential
• Annual hepatitis B serology:
HBsAg, HBeAg, anti-HBe, HBV DNA
• Liver ultrasound every 2 years
* To refer to SickKids Liver Clinic use our on-line referral system at: www.sickkids.ca/referralsystem/default.asp
SickKids Liver Clinic is happy to accept referrals for all children with hepatitis B. Our program offers
consultation and collaborative medical care, including treatment and patient and family education